New agents in acute myeloid leukemia (AML)

Despite expanding knowledge in the molecular landscape of acute myeloid leukemia (AML) and an increasing understanding of leukemogenic pathways, little has changed in the treatment of AML in the last 40 years. Since introduction in the 1970s, combination chemotherapy consisting of anthracycline and...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Silvia, Cho, Byung Sik, Kim, Hee-Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386889/
https://www.ncbi.nlm.nih.gov/pubmed/32719171
http://dx.doi.org/10.5045/br.2020.S003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386889/
https://www.ncbi.nlm.nih.gov/pubmed/32719171
http://dx.doi.org/10.5045/br.2020.S003

Ejemplares similares